Patents by Inventor Cordula Hopmann

Cordula Hopmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydroxyphenylundecane, a process for their production and their use
    Patent number: 7112608
    Abstract: The present invention relates to novel hydroxyphenylundecane derivatives of the formula (I), a method for the preparation of said compounds by cultivation of the fungus Cryphonectria parasitica, DSM 14453, and their use as pharmaceuticals, i.e. for the treatment of Alzheimer's Disease, Parkinson's Disease, Huntington's Diseases, stroke, psychosis and/or depressions.
    Type: Grant
    Filed: October 1, 2003
    Date of Patent: September 26, 2006
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Cordula Hopmann, Martin Knauf, Mark Brönstrup, Astrid Markus-Erb, Luigi Toti
  • Citrullimycines, a process for their production and their use as pharmaceuticals
    Patent number: 6930130
    Abstract: The present invention relates to novel active compounds named Citrullimycines, which are obtainable by cultivation of Streptomyces sp. ST 101396 (DSM 13309), and to their pharmaceutically acceptable salts and derivatives. The present invention further relates to a process for the production of the Citrullimycines, to the microorganism Streptomycetes sp. ST 101396 (DSM 13309), to the use of the Citrullimycines and their pharmaceutically acceptable salts and derivatives as pharmaceuticals, for example as inhibitors of the neurotensin receptor, and to pharmaceutical compositions comprising Citrullimycines or a pharmaceutically acceptable salt or derivative thereof.
    Type: Grant
    Filed: October 1, 2001
    Date of Patent: August 16, 2005
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Cordula Hopmann, Michael Kurz, Mark Brönstrup, Joachim Wink
  • Kinesin motor modulators derived from the marine sponge Adocia
    Publication number: 20040176625
    Abstract: This invention provides novel compounds derived from a marine sponge, Adocia sp., that specifically modulat kinesin activity by targeting the kinesin motor domain and mimicking the activity a microtubule. The compounds act as potent anti-mitogens are useful in a wide variety of in vitro and in vivo applications.
    Type: Application
    Filed: March 3, 2004
    Publication date: September 9, 2004
    Applicant: The Regents of the University of California
    Inventors: Lawrence S.B. Goldstein, David John Faulkner, Roman Sakowicz, Michael S. Berdelis, Christine L. Blackburn, Cordula Hopmann
  • Kinesin motor modulators derived from the marine sponge Adocia
    Patent number: 6777200
    Abstract: This invention provides novel compounds derived from a marine sponge, Adocia sp., that specifically modulat kinesin activity by targeting the kinesin motor domain and mimicking the activity a microtubule. The compounds act as potent anti-mitogens are useful in a wide variety of in vitro and in vivo applications.
    Type: Grant
    Filed: November 27, 2002
    Date of Patent: August 17, 2004
    Assignee: The Regents of the University of California
    Inventors: Lawrence S. B. Goldstein, David John Faulkner, Roman Sakowicz, Michael S. Berdelis, Christine L. Blackburn, Cordula Hopmann
  • Hydroxyphenylundecane, a process for their production and their use
    Publication number: 20040122092
    Abstract: The present invention relates to novel hydroxyphenylundecane derivatives of the formula (I), 1
    Type: Application
    Filed: October 1, 2003
    Publication date: June 24, 2004
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Cordula Hopmann, Martin Knauf, Mark Bronstrup, Astrid Markus-Erb, Luigi Toti
  • Amycomycin, a process for its production and its use as a pharmaceutical
    Patent number: 6642391
    Abstract: A compound named Amycomycin of the formula: is described, as well as its pharmaceutically acceptable salts and derivatives, in all their stereoisomeric and tautomeric forms. The compound is obtained by growing the microorganism Amycolatopsis species ST101170 (DSM 12216) and is useful as a pharmaceutical, particularly as an antibiotic.
    Type: Grant
    Filed: December 7, 2000
    Date of Patent: November 4, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Cordula Hopmann, Michael Kurz, Heinrich Decker, Dominique Le Beller, Jozsef Aszodi
  • Percyquinnin, a process for its production and its use as a pharmaceutical
    Patent number: 6596518
    Abstract: The present invention relates to a compound named Percyquinnin that is obtainable by cultivating a basidiomycetes Stereum complicatum (DSM 13303), and to its pharmaceutically acceptable salts. The present invention further relates to a process for the production of Percyquinnin and to the use of Percyquinnin and its pharmaceutically acceptable salts as pharmaceuticals, in particular to their use as inhibitors of lipase.
    Type: Grant
    Filed: April 6, 2001
    Date of Patent: July 22, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Cordula Hopmann, Michael Kurz, Guenter Mueller, Luigi Toti
  • Kinesin motor modulators derived from the marine sponge adocia
    Publication number: 20030127621
    Abstract: This invention provides novel compounds derived from a marine sponge, Adocia sp., that specifically modulat kinesin activity by targeting the kinesin motor domain and mimicking the activity a microtubule. The compounds act as potent anti-mitogens are useful in a wide variety of in vitro and in vivo applications.
    Type: Application
    Filed: November 27, 2002
    Publication date: July 10, 2003
    Inventors: Lawrence S.B. Goldstein, David John Faulkner, Roman Sakowicz, Michael S. Berdelis, Christine L. Blackburn, Cordula Hopmann
  • Vancoresmycin, a process for its production and its use as a pharmaceutical
    Publication number: 20020183267
    Abstract: The present invention relates to a compound named Vancoresmycin which is obtainable by cultivation of the microorganism HIL-006734 (DSM 12216), and to its pharmaceutically acceptable salts. The present invention further relates to a process for the production of Vancoresmycin, to the microorganism HIL-006734 (DSM 12216), to the use of Vancoresmycin and its pharmaceutically acceptable salts as pharmaceuticals, and in particular to their use as antibiotics, and to pharmaceutical compositions comprising Vancoresmycin or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 25, 2002
    Publication date: December 5, 2002
    Inventors: Nirogi Venkata Satya Ramakrishna, Ravi Gaianan Bhat, Eyyammadichiyil Sankaranarayanan Sreekumar, Erra Koteswara Satya Vijayakumar, Shantilal Dayaram Naker, Uttara Vinayak Oak, Rajendra Prakash Tanpure, Cordula Hopmann, Michael Kurz, Joachim Wink, Gerhard Seibert, Dominique Le Beller, Jozsef Aszodi
  • Kinesin motor modulators derived from the marine sponge Adocia
    Patent number: 6489134
    Abstract: This invention provides novel compounds derived from a marine sponge, Adocia sp., that specifically modulat kinesin activity by targeting the kinesin motor domain and mimicking the activity a microtubule. The compounds act as potent anti-mitogens are useful in a wide variety of in vitro and in vivo applications.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: December 3, 2002
    Assignee: The Regents of the University of California
    Inventors: Lawrence S.B. Goldstein, David John Faulkner, Roman Sakowicz, Michael S. Berdelis, Christine L. Blackburn, Cordula Hopmann
  • Citrullimycines, a process for their production and their use as pharmaceuticals
    Publication number: 20020065316
    Abstract: The present invention relates to novel active compounds named Citrullimycines, which are obtainable by cultivation of Streptomyces sp. ST 101396 (DSM 13309), and to their pharmaceutically acceptable salts and derivatives. The present invention further relates to a process for the production of the Citrullimycines, to the microorganism Streptomycetes sp. ST 101396 (DSM 13309), to the use of the Citrullimycines and their pharmaceutically acceptable salts and derivatives as pharmaceuticals, for example as inhibitors of the neurotensin receptor, and to pharmaceutical compositions comprising Citrullimycines or a pharmaceutically acceptable salt or derivative thereof.
    Type: Application
    Filed: October 1, 2001
    Publication date: May 30, 2002
    Inventors: Cordula Hopmann, Michael Kurz, Mark Bronstrup, Joachim Wink
  • Vancoresmycin, a process for its production and its use as a pharmaceutical
    Patent number: 6387943
    Abstract: The present invention relates to a compound named Vancoresmycin which is obtainable by cultivation of the microorganism HIL-006734 (DSM 12216), and to its pharmaceutically acceptable salts. The present invention further relates to a process for the production of Vancoresmycin, to the microorganism HIL-006734 (DSM 12216), to the use of Vancoresmycin and its pharmaceutically acceptable salts as pharmaceuticals, and in particular to their use as antibiotics, and to pharmaceutical compositions comprising Vancoresmycin or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: May 14, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Nirogi Venkata Satya Ramakrishna, Ravi Gajanan Bhat, Eyyammadichiyil Sankaranarayanan Sreekumar, Erra Koteswara Satya Vijayakumar, Shantilal Dayaram Naker, Uttara Vinayak Oak, Rajendra Prakash Tanpure, Cordula Hopmann, Michael Kurz, Joachim Wink, Gerhard Seibert, Dominique Le Beller, Jozsef Aszodi
  • Percyquinnin, a process for its production and its use as a pharmaceutical
    Publication number: 20020039768
    Abstract: The present invention relates to a compound named Percyquinnin which is obtainable by cultivation of the fungus Basidiomycetes Stereum complicatum (DSM 13303), and to its pharmaceutically acceptable salts. The present invention further relates to a process for the production of Percyquinnin, to the microorganism Basidiomycetes Stereum complicatum (DSM 13303), to the use of Percyquinnin and its pharmaceutically acceptable salts as pharmaceuticals, in particular to their use as inhibitor of lipase, and to pharmaceutical compositions comprising Percyquinnin or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 6, 2001
    Publication date: April 4, 2002
    Inventors: Cordula Hopmann, Michael Kurz, Guenter Mueller, Luigi Toti
  • Stromelysin inhibitors
    Patent number: 6337411
    Abstract: Compounds of the formula I are suitable for the production of pharmaceuticals for the prophylaxis and therapy of conditions whose course involves an increased activity of matrix-degrading enzymes, in particular stromelysin.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: January 8, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Cordula Hopmann, Martin Albert Knauf, Klaus-Ulrich Weithmann, Joachim Wink
  • Novel stromelysin inhibitors
    Publication number: 20010025029
    Abstract: Compounds of the formula I 1
    Type: Application
    Filed: December 15, 2000
    Publication date: September 27, 2001
    Inventors: Cordula Hopmann, Martin Albert Knauf, Klaus-Ulrich Weithmann, Joachim Wink
  • Amycomycin, a process for its production and its use as a pharmaceutical
    Publication number: 20010018450
    Abstract: A compound named Amycomycin of the formula: 1
    Type: Application
    Filed: December 7, 2000
    Publication date: August 30, 2001
    Inventors: Cordula Hopmann, Michael Kurz, Heinrich Decker, Dominique Le Beller, Jozsef Aszodi
  • Kinesin motor modulators derived from the marine sponge Adocia
    Patent number: 6207403
    Abstract: This invention provides novel compounds derived from a marine sponge, Adocia sp., that specifically modulat kinesin activity by targeting the kinesin motor domain and mimicking the activity a microtubule. The compounds act as potent anti-mitogens are useful in a wide variety of in vitro and in vivo applications.
    Type: Grant
    Filed: January 6, 1999
    Date of Patent: March 27, 2001
    Assignee: The Regents of the University of California
    Inventors: Lawrence S. B. Goldstein, David John Faulkner, Roman Sakowicz, Michael S. Berdelis, Christine L. Blackburn, Cordula Hopmann